← Leaderboards
David Myung
Stanford University
$3,647,115
Attributed
$4,161,440
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,161,440 · 3
VA$0 · 1
By mechanism
R01$3,046,640 · 2
K08$1,114,800 · 1
I21$0 · 1
Top collaborators
- Sarah C Heilshorn2 shared
Most similar at Stanford University
Same institution · by research overlap
- Christopher N Ta$1,960,496
- Michael T Longaker$26,931,387
- Michelle S Huang$113,017
- Neil Baugh$86,202
- Lei Cai$63,652
Others in their field
Other Emerging Leaders on “Natural Regeneration”
- Wuqiang Zhu · Mayo Clinic Arizona$6,493,351
- Charles Bernick · Athira Pharma, Inc.$6,312,103
- Hans Joerg Moebius · Athira Pharma, Inc.$6,312,103
- Hae Lin Jang · University Of California Los Angeles$5,700,472
- Steven L Stice · Georgia Tech Research Corporation$5,636,287
- Maribella Domenech-Garcia · Georgia Tech Research Corporation$5,636,287
Research focus
Natural RegenerationIn VitroCrosslinkCellsEncapsulatedCollagenChemistryProteinsMechanicsTissuesEngineeringCicatrixCorneaRegenerativeCorneal InjuryCatalystCopperGrowth FactorIn SituModalityWoundAzidesAlkynesCell Survival
Grant awards (14)
3D bioprinting of a bilayered, tissue engineered cornea$532,313
R01 · FY2025 · EY
Corneal Scar Repair through SPAACKL: Sutureless, Pro-regenerative Anterior Additive Collagen gel KeratopLasty$498,999
R01 · FY2025 · EY · contact PI
Corneal Scar Repair through SPAACKL: Sutureless, Pro-regenerative Anterior Additive Collagen gel KeratopLasty$498,999
R01 · FY2024 · EY · contact PI
3D bioprinting of a bilayered, tissue engineered cornea$496,338
R01 · FY2024 · EY
Corneal Scar Repair through SPAACKL: Sutureless, Pro-regenerative Anterior Additive Collagen gel KeratopLasty$506,869
R01 · FY2023 · EY · contact PI
Corneal Scar Repair through SPAACKL: Sutureless, Pro-regenerative Anterior Additive Collagen gel KeratopLasty$513,122
R01 · FY2022 · EY · contact PI
In Situ Bioconjugation as a Therapeutic Delivery Modality to Enhance Ocular Wound Healing$222,960
K08 · FY2021 · EY · contact PI
Corneal Reconstruction through an In Situ-Forming Collagen Gel$0
I21 · FY2021 · VA · contact PI
In Situ Bioconjugation as a Therapeutic Delivery Modality to Enhance Ocular Wound Healing$222,960
K08 · FY2020 · EY · contact PI
Corneal Reconstruction through an In Situ-Forming Collagen Gel$0
I21 · FY2020 · VA · contact PI
In Situ Bioconjugation as a Therapeutic Delivery Modality to Enhance Ocular Wound Healing$222,960
K08 · FY2019 · EY · contact PI
Corneal Reconstruction through an In Situ-Forming Collagen Gel$0
I21 · FY2019 · VA · contact PI
In Situ Bioconjugation as a Therapeutic Delivery Modality to Enhance Ocular Wound Healing$222,960
K08 · FY2018 · EY · contact PI
In Situ Bioconjugation as a Therapeutic Delivery Modality to Enhance Ocular Wound Healing$222,960
K08 · FY2017 · EY · contact PI